34675988|t|Inhibition of the Immunoproteasome Subunit LMP7 Ameliorates Cerebral White Matter Demyelination Possibly via TGFbeta/Smad Signaling.
34675988|a|OBJECTIVES: Chronic cerebral hypoperfusion induces white matter ischemic injury and cognitive impairment, whereas the mechanism remains unclear. Immunoproteasomes have been implicated in the pathogenesis of acute ischemia stroke and multiple sclerosis. However, the expression and role of immunoproteasomes in the brain of chronic cerebral hypoperfusion remain to be clarified. METHODS: Chronic white matter ischemic injury mice models were induced by bilateral carotid artery stenosis (BCAS). A selective immunoproteasome subunit low-molecular-mass peptide-7 (LMP7) inhibitor PR957 was administered to mice. Cognitive function, white matter integrity, and potential pathways were assessed after BCAS. RESULTS: The present study found that chronic cerebral hypoperfusion following BCAS induced cerebral white matter demyelination and cognitive impairment, accompanied with elevated expression of the immunoproteasomes LMP2 and LMP7, activation of astrocytes and microglia, and increased production of inflammatory cytokines (e.g., interleukin-1beta (IL-1beta), tumor necrosis factor-alpha (TNF-alpha), IL-10, transforming growth factor-beta1 (TGFbeta1), and insulin-like growth factor-1 (IGF-1)). However, inhibition of LMP7 with the specific proteasome inhibitor PR957 significantly mitigated the histological damage of the white matter, suppressed inflammatory response, and paralleled by an improvement of cognitive function. Furthermore, treatment of PR957 significantly upregulated the level of TGFbeta1, the total expression level, and the phosphorylation level of Smad2/3 and promoted brain remyelination. Surprisingly, PR957 alone had no effects on the neuroinflammation response and the activation of TGFbeta/Smad signaling in the sham-operated (BCAS-nonoperated) mice. CONCLUSIONS: The possible mechanism underlying this was attributed to that the immunoproteasome regulates TGFbeta/Smad signaling-mediated neuroinflammation and oligodendrocyte remyelination.
34675988	43	47	LMP7	Gene	16913
34675988	60	95	Cerebral White Matter Demyelination	Disease	MESH:D020278
34675988	109	116	TGFbeta	Gene	21803
34675988	153	175	cerebral hypoperfusion	Disease	MESH:D002547
34675988	184	212	white matter ischemic injury	Disease	MESH:D056784
34675988	217	237	cognitive impairment	Disease	MESH:D003072
34675988	340	361	acute ischemia stroke	Disease	MESH:D020521
34675988	366	384	multiple sclerosis	Disease	MESH:D009103
34675988	464	486	cerebral hypoperfusion	Disease	MESH:D002547
34675988	528	556	white matter ischemic injury	Disease	MESH:D056784
34675988	557	561	mice	Species	10090
34675988	595	618	carotid artery stenosis	Disease	MESH:D016893
34675988	620	624	BCAS	Disease	MESH:D016893
34675988	664	692	low-molecular-mass peptide-7	Gene	16913
34675988	694	698	LMP7	Gene	16913
34675988	710	715	PR957	Chemical	MESH:C542291
34675988	736	740	mice	Species	10090
34675988	768	774	matter	Disease	MESH:D056784
34675988	829	833	BCAS	Disease	MESH:D016893
34675988	881	903	cerebral hypoperfusion	Disease	MESH:D002547
34675988	914	918	BCAS	Disease	MESH:D016893
34675988	927	962	cerebral white matter demyelination	Disease	MESH:D020278
34675988	967	987	cognitive impairment	Disease	MESH:D003072
34675988	1051	1055	LMP2	Gene	16912
34675988	1060	1064	LMP7	Gene	16913
34675988	1164	1181	interleukin-1beta	Gene	16176
34675988	1183	1191	IL-1beta	Gene	16176
34675988	1194	1221	tumor necrosis factor-alpha	Gene	21926
34675988	1223	1232	TNF-alpha	Gene	21926
34675988	1235	1240	IL-10	Gene	16153
34675988	1242	1274	transforming growth factor-beta1	Gene	21803
34675988	1276	1284	TGFbeta1	Gene	21803
34675988	1291	1319	insulin-like growth factor-1	Gene	16000
34675988	1321	1326	IGF-1	Gene	16000
34675988	1353	1357	LMP7	Gene	16913
34675988	1397	1402	PR957	Chemical	MESH:C542291
34675988	1444	1453	damage of	Disease	MESH:D020263
34675988	1464	1470	matter	Disease	MESH:D056784
34675988	1483	1495	inflammatory	Disease	MESH:D007249
34675988	1588	1593	PR957	Chemical	MESH:C542291
34675988	1633	1641	TGFbeta1	Gene	21803
34675988	1704	1711	Smad2/3	Gene	17126;17127
34675988	1760	1765	PR957	Chemical	MESH:C542291
34675988	1794	1811	neuroinflammation	Disease	MESH:D000090862
34675988	1843	1850	TGFbeta	Gene	21803
34675988	1888	1892	BCAS	Disease	MESH:D016893
34675988	1906	1910	mice	Species	10090
34675988	2018	2025	TGFbeta	Gene	21803
34675988	2050	2067	neuroinflammation	Disease	MESH:D000090862
34675988	Positive_Correlation	MESH:D016893	16153
34675988	Positive_Correlation	16176	16913
34675988	Positive_Correlation	MESH:D016893	16912
34675988	Positive_Correlation	MESH:C542291	17127
34675988	Positive_Correlation	MESH:D016893	21926
34675988	Positive_Correlation	MESH:D020278	16912
34675988	Positive_Correlation	MESH:D002547	16913
34675988	Negative_Correlation	MESH:C542291	MESH:D007249
34675988	Positive_Correlation	MESH:D016893	16000
34675988	Positive_Correlation	MESH:D016893	16176
34675988	Positive_Correlation	MESH:C542291	17126
34675988	Positive_Correlation	MESH:C542291	21803
34675988	Association	MESH:D003072	16913
34675988	Positive_Correlation	MESH:D002547	16153
34675988	Association	MESH:D007249	16913
34675988	Positive_Correlation	MESH:D002547	16000
34675988	Positive_Correlation	MESH:D002547	16912
34675988	Negative_Correlation	MESH:C542291	MESH:D056784
34675988	Association	MESH:D000090862	21803
34675988	Positive_Correlation	MESH:D002547	16176
34675988	Positive_Correlation	MESH:D002547	21803
34675988	Association	MESH:D020278	21803
34675988	Positive_Correlation	MESH:D002547	21926
34675988	Negative_Correlation	MESH:C542291	16913
34675988	Association	MESH:D020278	16913
34675988	Negative_Correlation	MESH:C542291	MESH:D020263
34675988	Positive_Correlation	MESH:D016893	16913
34675988	Association	16913	21803

